Figure 1. Patients who filled controlled substance prescriptions within six months before medical cannabis certification.

Of all patients with osteoarthritis (n=117), 48 were actively consuming opioids. Patients who had surgery within six months of medical cannabis certification (n=8) were excluded. Our final study population included 40 patients.